Correlation Between ATyr Pharma and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on ATyr Pharma and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Pasithea Therapeutics.
Diversification Opportunities for ATyr Pharma and Pasithea Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ATyr and Pasithea is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Pasithea Therapeutics
If you would invest (100.00) in ATyr Pharma on September 17, 2024 and sell it today you would earn a total of 100.00 from holding ATyr Pharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 0.0% |
Values | Daily Returns |
ATyr Pharma vs. Pasithea Therapeutics Corp
Performance |
Timeline |
ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pasithea Therapeutics |
ATyr Pharma and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATyr Pharma and Pasithea Therapeutics
The main advantage of trading using opposite ATyr Pharma and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |